Abstract
Skin cancer, also known as melanoma, is generally diagnosed visually from the dermoscopic images, which is a tedious and time-consuming task for the dermatologist. Such a visual assessment, via the naked eye for skin cancers, is a challenging and arduous due to different artifacts such as low contrast, various noise, presence of hair, fiber, and air bubbles, etc. This article proposes a robust and automatic framework for the Skin Lesion Classification (SLC), where we have integrated image augmentation, Deep Convolutional Neural Network (DCNN), and transfer learning. The proposed framework was trained and tested on publicly available IEEE International Symposium on Biomedical Imaging (ISBI)-2017 dataset. The obtained average area under the receiver operating characteristic curve (AUC), recall, precision, and F1-score are respectively 0.87, 0.73, 0.76, and 0.74 for the SLC. Our experimental studies for lesion classification demonstrate that the proposed approach can successfully distinguish skin cancer with a high degree of accuracy, which has the capability of skin lesion identification for melanoma recognition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This manuscript has been seen and approved by all listed authors.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We use a publicly available ISIC dataset, which is free for the researchers.
